The acute contractile function of the heart is controlled by the effects of
released nonepinephrine (NE) on cardiac adrenergic receptors, NE can also
act in a more chronic fashion to induce cardiomyocyte growth, characterized
by cell enlargement (hypertrophy), increased protein synthesis, alteration
s in gene expression and addition of sarcomeres. These responses enhance ca
rdiomyocyte contractile function and thus allow the heart to compensate for
increased stress. The hypertrophic effects of NE are mediated through Gq-c
oupled alpha (1)-adrenergic receptors and are mimicked by the actions of ot
her neurohormones (endothelin, prostaglandin F-2 alpha angiotensin II) that
also act on Gq-coupled receptors, Activation of phospholipase C by Gq is n
ecessary for these responses, and protein kinase C and MAP kinases have als
o been implicated. Gq stimulated cardiac hypertrophy is also evident in tra
nsgenic mouse models. In contrast, stimulation of G(s)-coupled beta -adrene
rgic receptors or G(i)-coupled receptors do not directly effect cardiomyocy
te hypertrophy, Apoptosis is also induced by G-protein-coupled receptor sti
mulation in cardiomyocytes, Sustained or excessive activation of either Gq-
or Gs-signaling pathways results in apoptotic loss of cardiomyocytes both
in vitro and in vivo, Apoptosis is associated with decreased ventricular fu
nction in the failing heart, Cardiomyocytes provide an ideal model system f
or understanding the basis for G-protein mediated hypertrophy and apoptosis
, and the mechanisms responsible for the transition from compensatory to de
leterious levels of signaling. This information may prove critical for desi
gning interventions that prevent the pathophysiological consequences of hea
rt failure.